Trimodality treatment of malignant pleural mesothelioma.

Batirel, Hasan Fevzi; Metintas, Muzaffer; Caglar, Hale Basak; Yildizeli, Bedrettin; Lacin, Tunc; Bostanci, Korkut; Akgul, Asli Gul; Evman, Serdar; Yuksel, Mustafa

Batirel, Hasan Fevzi; Metintas, Muzaffer; Caglar, Hale Basak; Yildizeli, Bedrettin; Lacin, Tunc; Bostanci, Korkut; Akgul, Asli Gul; Evman, Serdar; Yuksel, Mustafa.

Affiliation

Batirel HF; Marmara University Hospital, Department of Thoracic Surgery, Istanbul, Turkey. hbatirel@marmara.edu.tr

J Thorac Oncol ; 3(5): 499-504, 2008 May.

Article in En | MEDLINE | ID: mdl-18449002

Subject(s)

Mesothelioma/therapy; Pleural Neoplasms/therapy; Adult; Aged; Chemotherapy, Adjuvant; Combined Modality Therapy; Feasibility Studies; Female; Humans; Lymphatic Metastasis; Male; Mesothelioma/mortality; Mesothelioma/pathology; Middle Aged; Neoplasm Staging; Pleural Neoplasms/mortality; Pleural Neoplasms/pathology; Pneumonectomy; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pleural Neoplasms / Mesothelioma Type of study: Guideline Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Thorac Oncol Year: 2008 Document type: Article Affiliation country: Turkey Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google